Meeting
2013 Gastrointestinal Cancers Symposium
Prognostic factors after R2 surgery in patients with advanced gastric cancer.
Authors
Masanori Tokunaga
Shizuoka Cancer Center
Masanori Tokunaga , Hironobu Goto , Rie Makuuchi , Yutaka Tanizawa , Etsuro Bando , Taiichi Kawamura , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr140)
DOI
10.1200/jco.2013.31.4_suppl.140
Abstract #
140
Poster Bd #
C28
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Role of palliative resection in patients with incurable advanced gastric cancer unfit for chemotherapy.
First Author: Wataru Takagi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Advantages of robotic surgery for advanced gastric cancer in short-term outcomes: A single-center retrospective study using propensity score matching.
First Author: Masaru Komatsu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Correlation between postoperative systemic inflammatory response and prognosis in patients with advanced gastric cancer.
First Author: Kenji Kuroda
Poster
2019 ASCO Annual Meeting
A phase II study of S-1, oxaliplatin, and nab-paclitaxel, and itraconazole aimed at conversion surgery for advanced and recurrent gastric cancer.
First Author: Yoshihiko Nakamoto